Tg Therapeutics (TGTX) Income from Non-Controlling Interests (2010 - 2012)

Tg Therapeutics' Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at -$8.1 million for Q3 2012.

• In Q3 2012, Income from Non-Controlling Interests fell 534199.07% year-over-year to -$8.1 million; the TTM figure through Sep 2013 stood at -$8.1 million (up 65.0% YoY), while the FY2012 annual figure was -$8.1 million, down 22430.3% from the prior year.
• Income from Non-Controlling Interests for Q3 2012 stood at -$8.1 million, down from -$7.8 million in the prior quarter.
• The five-year high for Income from Non-Controlling Interests was $2419.0 in Q4 2010, with the low at -$8.1 million in Q3 2012.
• The 3-year median for Income from Non-Controlling Interests is -$19592.0 (2011), against an average of -$3.3 million.
• The sharpest annual moves came in 2011 and 2012: Income from Non-Controlling Interests sank 909.92% in 2011, then sank 534199.07% in 2012.
• Tg Therapeutics' Income from Non-Controlling Interests stood at $2419.0 in 2010, then tumbled by 909.92% to -$19592.0 in 2011, then tumbled by 41079.64% to -$8.1 million in 2012.
• Business Quant data shows TGTX's Income from Non-Controlling Interests at -$8.1 million in Q3 2012, -$7.8 million in Q2 2012, and -$7.1 million in Q1 2012.